Algorhythm Holdings, Inc. Announces Pricing of $9.5 Million Public Offering
05 déc. 2024 08h45 HE
|
Algorhythm Holdings, Inc.
Fort Lauderdale, FL, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm” or the “Company”) (NASDAQ: RIME), an AI-driven technology and consumer electronics holding company,...
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
25 nov. 2024 16h00 HE
|
Autonomix Medical, Inc.
THE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted...
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
14 nov. 2024 16h30 HE
|
GlucoTrack, Inc.
Rutherford, NJ., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and commercialization of novel technologies for...
Stryve Foods, Inc. Announces Closing of $2.9 Million Public Offering
12 nov. 2024 12h15 HE
|
Stryve Foods, Inc.
Stryve Foods, Inc. (Nasdaq: SNAX) Announces Closing of $2.9 Million Public Offering
ProPhase Labs Announces Pricing of Public Offering of Common Stock
07 nov. 2024 23h37 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the...
ProPhase Labs Announces Proposed Public Offering of Common Stock
07 nov. 2024 16h05 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next-generation biotech, genomics and diagnostics company, today announced that it intends to offer to sell...
CNL Strategic Capital Launches Second Follow-On Offering of $1.1 Billion
01 nov. 2024 17h11 HE
|
CNL Strategic Capital
Orlando, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- CNL Strategic Capital, a public, non-traded company that seeks to provide current income and long-term appreciation to its investors, has launched...
Marex Group plc Announces Launch of a Public Offering
21 oct. 2024 16h53 HE
|
Marex Group plc
MAREX GROUP PLC ANNOUNCES LAUNCH OF A PUBLIC OFFERING
Altamira Therapeutics Announces Closing of up to $12.0 Million Public Offering
19 sept. 2024 16h01 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 19, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked...
Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering
17 sept. 2024 17h00 HE
|
Altamira Therapeutics Ltd
Hamilton, Bermuda, Sept. 17, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked...